SG114650A1 - Cyclocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclocarbamate derivatives as progesterone receptor modulators

Info

Publication number
SG114650A1
SG114650A1 SG200400080A SG200400080A SG114650A1 SG 114650 A1 SG114650 A1 SG 114650A1 SG 200400080 A SG200400080 A SG 200400080A SG 200400080 A SG200400080 A SG 200400080A SG 114650 A1 SG114650 A1 SG 114650A1
Authority
SG
Singapore
Prior art keywords
receptor modulators
progesterone receptor
cyclocarbamate
derivatives
cyclocarbamate derivatives
Prior art date
Application number
SG200400080A
Inventor
Puwen Zhang
A Terefenko Eugene
Fletcher Horace
Fensome Andrew
E Wrobel Jay
Lin Zhi
K Jones Todd
M Tegley Christopher
Original Assignee
American Home Prod
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by American Home Prod, Ligand Pharm Inc filed Critical American Home Prod
Publication of SG114650A1 publication Critical patent/SG114650A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
SG200400080A 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators SG114650A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
SG114650A1 true SG114650A1 (en) 2005-09-28

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200400080A SG114650A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Country Status (19)

Country Link
EP (1) EP1173426A1 (en)
JP (1) JP2002543193A (en)
KR (1) KR20010114250A (en)
CN (1) CN1145618C (en)
AU (1) AU766428B2 (en)
BG (1) BG106079A (en)
BR (1) BR0010213A (en)
CA (1) CA2371726A1 (en)
CZ (1) CZ20013951A3 (en)
EA (1) EA004512B1 (en)
HU (1) HUP0201609A3 (en)
IL (1) IL146280A0 (en)
MX (1) MXPA01011286A (en)
NO (1) NO321361B1 (en)
NZ (1) NZ515355A (en)
PL (1) PL351127A1 (en)
SG (1) SG114650A1 (en)
SK (1) SK15912001A3 (en)
TR (1) TR200103286T2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510278A (en) * 2004-04-27 2007-10-30 Wyeth Corp method for producing compounds, product, and, compound
JPWO2006077821A1 (en) * 2005-01-19 2008-06-19 大日本住友製薬株式会社 Aromatic sulfone compounds as aldosterone receptor modulators
US8314094B2 (en) 2007-10-05 2012-11-20 Msd K.K Benzoxazinone derivative
CN111925353B (en) * 2020-08-31 2022-04-08 苏州大学附属第二医院 Preparation method of 2-thiophenecarbonitrile

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
WO1996019458A2 (en) * 1994-12-22 1996-06-27 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
WO1998014436A1 (en) * 1996-10-02 1998-04-09 Dupont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
WO1996019458A2 (en) * 1994-12-22 1996-06-27 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
WO1998014436A1 (en) * 1996-10-02 1998-04-09 Dupont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
CN1349517A (en) 2002-05-15
CA2371726A1 (en) 2000-11-09
AU766428B2 (en) 2003-10-16
NZ515355A (en) 2004-02-27
CZ20013951A3 (en) 2002-05-15
NO321361B1 (en) 2006-05-02
CN1145618C (en) 2004-04-14
EA004512B1 (en) 2004-04-29
TR200103286T2 (en) 2002-07-22
NO20015378D0 (en) 2001-11-02
JP2002543193A (en) 2002-12-17
SK15912001A3 (en) 2002-06-04
EP1173426A1 (en) 2002-01-23
MXPA01011286A (en) 2003-07-14
BR0010213A (en) 2002-02-19
NO20015378L (en) 2002-01-03
HUP0201609A2 (en) 2002-08-28
BG106079A (en) 2002-05-31
IL146280A0 (en) 2002-07-25
EA200101176A1 (en) 2002-04-25
PL351127A1 (en) 2003-03-24
AU4688600A (en) 2000-11-17
KR20010114250A (en) 2001-12-31
HUP0201609A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
EG25606A (en) Glucocorticoid receptor modulators
HUP0204029A3 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HK1043788A1 (en) Tetracyclic progesterone receptor modulator compounds and methods
IL146223A0 (en) Steroid derivatives
EP1170020A4 (en) Patches for external use
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
MXPA01011294A (en) Tetracyclic progesterone receptor modulator compounds and methods.
HK1068875A1 (en) Tetracyclic heterocompounds as estrogen receptor modulators
IL154984A0 (en) Estrogen receptor modulators
HUP0203332A3 (en) Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them
IL146151A0 (en) Human-g-protein receptor
HK1047049A1 (en) Indole derivatives
HK1049161B (en) Indole derivatives
IL146280A0 (en) Cyclocarbamate derivatives as progesterone receptor modulators
GB9927215D0 (en) Hormone receptor expression
HK1043789A1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
HK1043989A1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
GB9913649D0 (en) Estrogen receptor
SI1235776T1 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HK1043988A1 (en) Indoline derivatives as progesterone antagonists
HK1043991A1 (en) Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
AU2002255847A1 (en) Aminopyridine derivatives as estrogen receptor modulators
SI1467998T1 (en) Tetracyclic heterocompounds as estrogen receptor modulators